The role of Ca 19-9 in progression, recurrence and survival of borderline resectable pancreatic cancer

被引：0
|
作者：
Almeida, C. [1 ]
Goncalves, M. [1 ]
Freitas, M. [1 ]
Teixeira, C. [1 ]
Couto, M. [1 ]
Lemos, T. [1 ]
Meireles, S. [1 ]
Rego, I. [1 ]
Sarmento, C. [1 ]
Coelho, A. [1 ]
Costa, A. [1 ]
Barbosa, M. [1 ]
机构：
[1] Ctr Hosp Sao Joao, Porto, Portugal
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.426
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-370
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 50 条
  • [21] Is CA 19-9 useful in the management of pancreatic cancer?
    Balzano, Gianpaolo
    Di Carlo, Valerio
    LANCET ONCOLOGY, 2008, 9 (02): : 89 - 91
  • [22] Exploiting the relevance of CA 19-9 in pancreatic cancer
    Salleh, Syaza
    Thyagarajan, Anita
    Sahu, Ravi P.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [23] RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy
    Bold, Richard J.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2108 - 2110
  • [24] Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma
    Adam C. Berger
    Ingrid M. Meszoely
    Eric A. Ross
    James C. Watson
    John P. Hoffman
    Annals of Surgical Oncology, 2004, 11 : 644 - 649
  • [25] Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma
    Berger, AC
    Meszoely, IM
    Ross, EA
    Watson, JC
    Hoffman, JP
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (07) : 644 - 649
  • [26] RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy
    Richard J. Bold
    Annals of Surgical Oncology, 2013, 20 : 2108 - 2110
  • [27] The impact of CA 19-9 on survival in patients with clinical stage I pancreatic cancer
    Melucci, Alexa D.
    Chacon, Alexander C.
    Burchard, Paul R.
    Ullman, Nicholas A.
    Tsagkalidis, Vasleios
    Casabianca, Anthony S.
    Reitz, Alexandra
    Swift, David A.
    Goyal, Subir
    Switchenko, Jeffrey M.
    Carpizo, Darren R.
    Shah, Mihir Maheshkumar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [28] Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival
    Heger, Ulrike
    Sun, Huihui
    Hinz, Ulf
    Klaiber, Ulla
    Tanaka, Masayuki
    Liu, Bing
    Sachsenmaier, Milena
    Springfeld, Christoph
    Michalski, Christoph W.
    Buechler, Markus W.
    Hackert, Thilo
    HPB, 2020, 22 (02) : 224 - 232
  • [29] Impact of CA 19-9 on Survival in Patients with Clinical Stage I Pancreatic Cancer
    Melucci, Alexa D.
    Chacon, Alexander C.
    Burchard, Paul R.
    Ullman, Nicholas A.
    Tsagkalidis, Vasleios
    Casabianca, Anthony S.
    Reitz, Alexandra C.
    Swift, David A.
    Goyal, Subir
    Switchenko, Jeffrey
    Carpizo, Darren R.
    Shah, Mihir M.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 445 - 446
  • [30] Preoperative prediction of survival in resectable gallbladder cancer by a combined utilization of CA 19-9 and carcinoembryonic antigen
    Yu Tunan
    Yu Hong
    Cai Xiujun
    CHINESE MEDICAL JOURNAL, 2014, 127 (12) : 2299 - 2303
12345